Testosterone treatment may decrease the risk of liver disease in men with obesity
26 May 2021
Testosterone treatment in men with obesity and type 2 diabetes may decrease their risk of developing non-alcoholic fatty liver disease, according to a study presented at the recent European Congress of Endocrinology.
